Tailoring immunisation programmes: Using behavioural insights to identify barriers and enablers to childhood immunisations in a Jewish community in London, UK

Letley, Louise; Rew, Vanessa; Ahmed, Rehana L.; Habersaat, Katrine Bach; Paterson, Pauline; Chantler, Tracey; Saavedra-Campos, María; Butler, Robb

doi:10.1016/j.vaccine.2018.06.028

Cited by 44 publications

(74 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To avoid missing fundamental challenges, all of the potential barriers (and drivers) to vaccination in the target groups need to be explored. In addition, experience shows that one cannot rely solely on assumptions among health workers or authorities about reasons for low vaccination coverage as these can be challenged or even disproven when barriers are explored in more depth [16]. For example, the influence of anti-vaccination messages on parents can be overrated, whilst the lack of an effective recall/reminder system may be overlooked.…”

Section: A Comprehensive Theoretical Modelmentioning

confidence: 99%

Understanding vaccine acceptance and demand—and ways to increase them

Habersaat

Jackson

2019

Bundesgesundheitsbl

Self Cite

135

142

View full text Add to dashboard Cite

Vaccination saves millions of lives, and the World Health Organization (WHO) European Region celebrated record high coverage in 2018. Still, national or sub-national coverage is insufficient to stop the spread of vaccine-preventable diseases. Health authorities are increasingly aware of the need to prioritize the “demand” side of vaccination. Achieving high and equitable vaccination uptake in all population groups is not a quick-fix; it requires long-term investment in multifaceted interventions, informed by research with the target groups. The WHO focuses on both individual and context determinants of vaccination behaviours. Individual determinants include risk perceptions, (dis)trust and perceived constraints; insights from psychology help us understand these. Context determinants include social norms, socioeconomic status and education level, and the way health systems are designed, operate and are financed. The WHO recommends using a proven theoretical model to understand vaccination behaviours and has adapted the “COM‑B model” for their Tailoring Immunization Programmes (TIP) approach. This adapted model is described in the article. Informed by insights into the factors affecting vaccination behaviours, interventions and policies can be planned to increase vaccination uptake. Some evidence exists on proven methods to do this. At the individual level, some interventions have been seen to increase vaccination uptake, and experimental studies have assessed how certain messages or actions affect vaccination perceptions. At the context level, there is more documentation for effective strategies, including those that focus on making vaccination the easy, convenient and default behaviour and that focus on the interaction between caregivers and health workers.

show abstract

Section: A Comprehensive Theoretical Modelmentioning

confidence: 99%

Understanding vaccine acceptance and demand—and ways to increase them

Habersaat

Jackson

2019

Bundesgesundheitsbl

Self Cite

135

142

View full text Add to dashboard Cite

show abstract

“…The UK has applied ‘Tailoring Immunisation Programme’ methodologies created by the WHO/Europe, for example, to the Orthodox Jewish Charedi community of North London. 83 The Tailoring Immunisation Programme is a framework that provides tools to identify low vaccine coverage groups, diagnose supply-side and demand-side immunisation barriers, identify motivators to vaccination and create evidence-based responses to sustain vaccination. 84…”

Section: Patient Educationmentioning

confidence: 99%

“…Routinely offering vaccinations during regular health checks, and providing information in local languages is also key to promoting vaccine uptake. 83 84…”

Section: Patient Educationmentioning

confidence: 99%

Protecting people with multiple sclerosis through vaccination

et al. 2020

View full text Add to dashboard Cite

Vaccines are key to preventing contagious, or serious, infections. However, their use in people with multiple sclerosis (pwMS) has often been problematic because of misguided concerns that vaccinations may exacerbate the disease and also because some disease-modifying therapies (DMTs) may influence the immune response to immunisations and/or their safety. PwMS may have higher morbidity and mortality from vaccine-preventable infections. It is, therefore, important to address any patient’s reluctance to accept vaccination and to provide clear guidance for clinicians on which vaccinations to consider proactively. We have reviewed the current literature and provide recommendations regarding vaccines in adults with MS, including specific advice regarding vaccination safety in patients receiving—or going to receive—DMTs, vaccination during pregnancy, pretravel counselling and patient education. Our aim is to endorse vaccination as one of the most efficient methods for protecting pwMS from infections and to provide a framework to ensure vaccinations are safe and effective.

show abstract

“…When a large number of unvaccinated individuals live in close proximity, their community becomes vulnerable to outbreaks. Better vaccine coverage across the whole population should be accompanied by targeted efforts to assess the risk, specific needs and characteristics of undervaccinated communities and, thereby, close any gaps in immunity 32 …”

Section: Discussionmentioning

confidence: 99%

Triangulation of measles vaccination data in the United Kingdom of Great Britain and Northern Ireland

Edelstein

White

Bukasa

et al. 2019

Bull. World Health Organ.

View full text Add to dashboard Cite

ObjectiveTo illustrate how data triangulation involving routine data sources can optimize data usage and provide insights into vaccine programme effectiveness by considering measles vaccination and disease incidence data in England.MethodsWe obtained data on measles, mumps and rubella (MMR) vaccine coverage in birth cohorts from 1985 to 2016 from child health records and adjusted for under-ascertainment and catch-up campaigns. We assumed that the population had no natural immunity and that vaccine effectiveness was 95% for one dose and 99.75% for two doses. Vaccinations done outside the routine schedule and in people who entered England after the age of immunization were identified from primary care records. Measles susceptibility was defined as the percentage of individuals who were not immune despite all vaccination activities. We triangulated measles susceptibility and incidence data.FindingsMedian susceptibility was 4.6% (range: 1.2–9.2). Among cohorts eligible for two MMR vaccine doses, those born between 1998 and 2004 were most susceptible. Measles incidence was highest in these cohorts. Data from primary care and child health records were comparable for cohorts after 2000, suggesting that little supplementary vaccination took place. For cohorts before 2000, primary care data quality was insufficient for accurately estimating coverage.ConclusionTriangulating routine data on measles vaccination coverage and disease surveillance provided new insights into population immunity and helped identify vulnerable groups, which was useful for prioritizing public health actions to close gaps in immunity. This approach could be applied in any country that routinely records vaccine coverage and disease incidence.

show abstract

Tailoring immunisation programmes: Using behavioural insights to identify barriers and enablers to childhood immunisations in a Jewish community in London, UK

Cited by 44 publications

References 7 publications

Understanding vaccine acceptance and demand—and ways to increase them

Understanding vaccine acceptance and demand—and ways to increase them

Protecting people with multiple sclerosis through vaccination

Triangulation of measles vaccination data in the United Kingdom of Great Britain and Northern Ireland

Contact Info

Product

Resources

About